Vanguard Fiduciary Trust
AMPH icon

Vanguard Fiduciary Trust’s Amphastar Pharmaceuticals AMPH Stock Holding History

Vanguard Fiduciary Trust’s Portfolio AMPH Stock Details AMPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.53M Sell
224,478
-6,566
-3% -$132K ﹤0.01% 2243
2026
Q1 		$4.53M Buy
+231,044
New +$5.65M ﹤0.01% 2130

Other funds holding AMPH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Fiduciary Trust's AMPH Position: Q2 2026 in Review

Vanguard Fiduciary Trust reduced its Amphastar Pharmaceuticals (AMPH) stake by 2.8% in Q2 2026, selling an estimated $132K and leaving 224,478 shares worth $4.53M. The position accounts for ﹤0.01% of the portfolio, ranked #2243.

Vanguard Fiduciary Trust first reported a position in AMPH in Q1 2026 and has held it in 2 quarters since. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.

  • Vanguard Fiduciary Trust held 224,478 shares of Amphastar Pharmaceuticals worth $4.53M as of Q2 2026.
  • Vanguard Fiduciary Trust sold 6,566 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $132K.
  • Amphastar Pharmaceuticals made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #2243 holding.
  • Vanguard Fiduciary Trust first reported a position in Amphastar Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.